Becky Hood
Alchem Laboratories (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Neonatal Health and Biochemistry, Computational Drug Discovery Methods, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Bidirectional modulation of HIF-2 activity through chemical ligands(2019)107 cited
- → Characterization of the Recombinant IKK1/IKK2 Heterodimer(2000)64 cited
- → Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes(2013)64 cited
- → Discovery of ML314, a Brain Penetrant Nonpeptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor(2013)48 cited
- → Discovery of a Plasmodium falciparum Glucose-6-phosphate Dehydrogenase 6-phosphogluconolactonase Inhibitor ( R , Z )- N -((1-Ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2 H -benzo[ b ][1,4]thiazine-6-carboxamide (ML276) That Reduces Parasite Growth in Vitro(2012)38 cited
- → Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)(2010)25 cited
- → Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress(2017)24 cited
- → Purification and characterization of Eikenella corrodens type IV pilin(1995)22 cited
- → Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening Assay(2022)22 cited
- → Eikenella corrodens Phase Variation Involves a Posttranslational Event in Pilus Formation(1999)20 cited